Effect of endogenous intestinal glucagon-like immunoreactivity (GLI) on insulin secretion and glucose concentration in dogs.
D000818:Animals; D001786:Blood Glucose / Q000032:analysis*; D004285:Dogs; D005632:Fructose / Q000494:pharmacology*; D005690:Galactose / Q000494:pharmacology*; D005934:Glucagon / Q000097:blood / Q000502:physiology*; D005947:Glucose / Q000378:metabolism; D006601:Hexoses / Q000494:pharmacology*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007408:Intestinal Absorption; D008112:Liver Glycogen / Q000378:metabolism; D008358:Mannose / Q000494:pharmacology*; D014994:Xylose / Q000494:pharmacology*
D001786:Blood Glucose; D006601:Hexoses; D007328:Insulin; D008112:Liver Glycogen; D005632:Fructose; D005934:Glucagon; D014994:Xylose; D005947:Glucose; D008358:Mannose; D005690:Galactose